Clustering data with hclust algorithm for Statin Immuno-Metabolomics in Asthma (part III) (Study ST000845)
Reversed phase NEGATIVE ION MODE (Analysis AN001368)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 |
|---|---|---|---|---|---|---|---|---|---|---|
| CA | ME224545 | 0.35 | 0.19 | 1.51 | 5.79 | 0.08 | 0.31 | 0.65 | 0.15 | 0.71 |
| CDCA | ME224546 | 0.29 | 0.56 | 1.35 | 6.38 | 0.19 | 1.16 | 0.44 | 0.16 | 1.07 |
| TCA | ME224547 | 0.55 | 0.48 | 0.15 | 2.19 | 0.43 | 0.37 | 5.74 | 0.25 | 0.13 |
| TDCA | ME224553 | 0.31 | 0.52 | 0.32 | 2.04 | 1.99 | 1.62 | 3.37 | 0.47 | 0.21 |
| GCA | ME224549 | 0.33 | 0.34 | 0.62 | 2.31 | 0.58 | 1.83 | 3.02 | 0.20 | 0.46 |
| TCDCA | ME224548 | 0.66 | 0.77 | 0.54 | 2.70 | 0.70 | 0.78 | 3.55 | 0.14 | 0.21 |
| TUDCA | ME224558 | 0.57 | 0.67 | 0.44 | 2.14 | 0.94 | 0.94 | 3.83 | 0.36 | 0.43 |
| GDCA | ME224554 | 0.14 | 0.25 | 0.44 | 1.23 | 1.71 | 5.01 | 1.28 | 0.33 | 0.78 |
| GCDCA | ME224550 | 0.38 | 0.49 | 1.11 | 1.50 | 0.86 | 3.08 | 1.63 | 0.17 | 0.80 |
| UDCA | ME224557 | 0.74 | 0.91 | 0.85 | 2.50 | 0.55 | 2.03 | 0.51 | 0.43 | 0.97 |
| GLCA | ME224555 | 0.46 | 0.55 | 0.68 | 1.38 | 0.82 | 2.60 | 0.74 | 1.44 | 1.66 |
| GHDCA | ME224556 | 0.82 | 0.84 | 0.90 | 1.09 | 1.07 | 1.53 | 1.19 | 0.91 | 1.08 |
| DCA | ME224551 | 0.72 | 0.85 | 0.77 | 1.76 | 0.63 | 1.75 | 0.60 | 1.21 | 1.34 |
| LCA | ME224552 | 0.76 | 0.88 | 0.78 | 1.30 | 0.93 | 1.16 | 0.79 | 1.68 | 1.30 |
Factors:
| F1 | Treatment:Control | Day:Day 0 |
| F2 | Treatment:Control | Day:Day 12 |
| F3 | Treatment:Control | Day:Day 8 |
| F4 | Treatment:Pravastatin | Day:Day 0 |
| F5 | Treatment:Pravastatin | Day:Day 12 |
| F6 | Treatment:Pravastatin | Day:Day 8 |
| F7 | Treatment:Simvastatin | Day:Day 0 |
| F8 | Treatment:Simvastatin | Day:Day 12 |
| F9 | Treatment:Simvastatin | Day:Day 8 |
